This inventor holds 1 USPTO granted patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Norbert Kraut: Innovator in Pharmaceutical Processes
Introduction
Norbert Kraut is a notable inventor based in Singen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. His work has implications for the treatment of various medical conditions, showcasing the importance of research and development in the pharmaceutical industry.
Latest Patents
Norbert Kraut holds a patent for "Processes for preparing a pan-JAK inhibitor and related intermediate compounds." This patent details processes for preparing a crystalline form of a specific compound, which is crucial for the development of effective therapeutic agents. The compound in question is 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, along with related intermediate compounds.
Career Highlights
Kraut is currently associated with Theravance Biopharma R&D IP, LLC, where he continues to advance his research in pharmaceutical processes. His expertise in this area has led to the development of innovative solutions that enhance drug efficacy and safety.
Collaborations
Throughout his career, Norbert has collaborated with esteemed colleagues, including Stephen Roseblade and Christian Pater. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Norbert Kraut's contributions to the field of pharmaceuticals through his innovative processes and collaborations highlight the vital role of inventors in advancing medical science. His work continues to impact the industry positively, paving the way for future developments in drug preparation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
